Carolina Molecular Inc. — Form D
Carolina Molecular Inc. of MORRISVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-13. The offering totals $1.7M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-11-13
- Form: D
- Accession: 0002096691-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.1M
- Remaining: $575K
- Investors: 8
- Date of first sale: 2025-09-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-563924
Issuer
- Name: Carolina Molecular Inc.
- CIK: 0002096691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 133 SOUTHCENTER COURT STE 400, MORRISVILLE, NC, 27560
- Phone: 9194217778
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Trent Carrier | Director | Seattle, WA |
| John Corliss | Director | Morrisville, NC |
| Max Weis | Director | Morrisville, NC |
| Trent Carrier | Executive Officer | Seattle, WA |
More